Skip to content
Search

Latest Stories

PDA calls for further steps to end violence against pharmacists; NPA, AIM back 'zero tolerance'

The Pharmacists' Defence Association (PDA) has called for further steps to end violence against pharmacists.

PDA’s latest call follows zero tolerance approach adopted by the community pharmacy sector.


The association has welcomed the sector’s approach against assault and is now calling the whole sector to work together with the union to deliver the next steps in a bid to end violence against pharmacy professionals.

The union has said in a statement: “…nobody should accept being abused, being threatened or being assaulted as part of their job, yet somehow for too many, too often that is the attitude that has been able to develop.”

It further noted: “Every time violence has been accepted, and the aggressor has avoided any consequences to their actions it has condemned colleagues to greater risk of reoccurrence. This cycle must stop now.”

The Health & Safety Executive (HSE) defines violence as “any incident in which a person is abused, threatened or assaulted in circumstances related to their work”.

The union has highlighted the fact that the sector needs to ensure that the public understand there is a genuine 'zero tolerance' of any form of violence in all community pharmacies.

The PDA encourages pharmacists to display posters against violence, which is now endorsed by the National Police Chiefs Council, in their respective pharmacies.

It urges pharmacists to alert the union if their employers acted to the contrary of the stated commitments against violence.

The PDA is calling on the whole pharmacy sector to work with the union to secure five measures including:

1. A zero-tolerance policy for violence towards staff working in a pharmacy, including verbal, sectarian or racist abuse directed towards pharmacists and pharmacy staff.

2. A requirement for every pharmacy owner to undertake a risk assessment at individual premises level and publish a clearly-defined statement on the risk of violence.

3. Measures appropriate to the situation, as identified by a risk assessment, are implemented to reduce the risks of violence.

4. Funding for security measures from the government to assist pharmacy contractors with their implementation.

5. Regulatory standards which place more robust requirements on pharmacy owners, superintendents, chief pharmacists and managers to ensure the safety of staff.

The Union has claimed that its campaign against violence has secured a significantly increased profile in these last few weeks.

“We have now obtained commitments from all major national community pharmacy employer organisations towards a zero-tolerance approach,” PDA states.

The National Pharmacy Association, who had already been promoting zero tolerance to their members for some time, have said: “The NPA has zero tolerance for violence or other forms of abuse in pharmacies.  The safety of pharmacists and pharmacy staff should never be in question.”

The Association of Independent Multiple Pharmacies has said: “AIM has always supported the zero tolerance of violence in pharmacies and our members take this matter very seriously.”

More For You

Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less